Oracle Alpha »

Nurix Therapeutics shares owned by Oracle Alpha

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Oracle Alpha from 13F filings

Historical chart of Oracle Alpha investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Oracle Alpha consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Oracle Alpha

Quarter filed Position value Share count Share price at filing
2023-12-31 $180k 17k 10.32

More positions owned by Oracle Alpha

Intel Corporation (INTC)
NVIDIA Corporation (NVDA)
Gitlab (GTLB)
Samsara (IOT)
Eli Lilly & Co. (LLY)
Thermo Fisher Scientific (TMO)
Snowflake Inc Cl A (SNOW)
Tesla Motors (TSLA)
Synchrony Financial (SYF)
Merck & Co (MRK)
Johnson & Johnson (JNJ)
Coinbase Global (COIN)
Procore Technologies (PCOR)
Brighthouse Finl (BHF)
Hess (HES)

View all positions for Oracle Alpha

Top funds holding Nurix Therapeutics

Baker Bros. Advisors
Redmile Group
ARK Investment Management
Vanguard Group
T. Rowe Price Associates
Daniel D. Thurber
Dimensional Fund Advisors
Candriam Luxembourg S.C.A.
Charles Schwab Investment Management
Deutsche Bank Aktiengesellschaft
Millennium Management
Bessemer
Arrowpoint Asset Management
Taddei, Ludwig & Associates
Goldman Sachs Group

View all funds holding Nurix Therapeutics